跳至主要内容
临床试验/IRCT20210216050373N3
IRCT20210216050373N3招募中3 期

The evaluation of effect of herbal supplement (Melissa Officinalis and Hypericum perforatum along with DDW water) on the improvement of clinical symptoms, CD4 level and the viral load of HIV positive patients: A randomized double blind clinical trial study

Vice Chancellor of Research, Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients must give their knowing and voluntary written consent to join the study
  • Patients must have at least two positive ELISA HIV test results
  • Patients who have failed to benefit from anti-retroviral drugs due to drug resistance

排除标准

  • Patients with undetectable levels of blood viral content
  • Patients with Hepatitis B or C
  • Pregnancy and lactation
  • Patients who have used immuno-enhancers; use of antibiotics and other prescribed medication to treat AIDS symptomology is excepted
  • Present use of illegal drugs or alcohol
  • Use of growth hormone 30 days prior to the study
  • Use of testosterone or anabolic steroids 30 days prior to the study
  • Chemotherapy, radiotherapy or interferon treatment 3 weeks prior to entering the study

研究者

发起方
Vice Chancellor of Research, Tehran University of Medical Sciences

相似试验